The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in asymptomatic heart failure subjects will improve their heart structure and thus prevent the progression to symptomatic disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
300
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Birmingham, Alabama, United States
Unnamed facility
Mobile, Alabama, United States
Unnamed facility
Little Rock, Arkansas, United States
Unnamed facility
Los Angeles, California, United States
Unnamed facility
Northridge, California, United States
Unnamed facility
Redondo Beach, California, United States
Unnamed facility
Riverside, California, United States
Research Site
Farmington, Connecticut, United States
Unnamed facility
Clearwater, Florida, United States
Unnamed facility
Melbourne, Florida, United States
...and 34 more locations